Client · LDA

BRISTOL-MYERS SQUIBB COMPANY

5 filings 18 bills mentioned 1 registrants 5 quarters ~$11,400,000 reported

Client ID

109642

Bills lobbied on

Bills referenced in this client's quarterly filings, ranked by filing count.

HR 7635

CHARGE Act

MMM

HR 1492

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

HCR

HR 4299

Protecting Patient Access to Cancer and Complex Therapies Act

HCR

S 1339

Stop CCP Money Laundering Act of 2025

PHA

HR 1

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

HCR

HR 3285

Student Loan Marriage Penalty Elimination Act of 2025

PHA

S 526

Pharmacy Benefit Manager Transparency Act of 2025

PHA

HR 1968

Full-Year Continuing Appropriations and Extensions Act, 2025

HCRPHA

HR 3521

Clinical Trial Modernization Act

PHA

S 864

HELP Copays Act

PHA

S 127

Whole-Home Repairs Act of 2025

PHA

HR 8412

To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to revise certain regulations related to infant and toddler beverages, and for other purposes.

PHA

HR 3283

FARMER Act

PHA

S 2973

SHUTDOWN Act

PHA

HR 5378

Tribal Healthcare Careers Act

PHA

HR 7391

Community Health Center Drug Pricing Protection Act

HCR

HR 830

SAFE Act

PHA

HR 5509

Safe Step Act

HCR

Registrants

Lobbying firms that filed on behalf of this client.

BRISTOL-MYERS SQUIBB COMPANY 5

Source: Senate LDA quarterly filings (LD-2). Bill mentions extracted from free-text "specific issues" descriptions.